Nasdaq-listed NewGenIvf Group Limited has announced the acquisition of 13,000.23 SOL and its involvement in a $10 million gold-backed asset tokenization project, as revealed in its latest financial report. The report, dated November 28, also highlighted a net profit of $17.5 million for the third quarter. Additionally, NewGen's board has approved a 24-month stock buyback program valued at $2 million, reflecting the company's strategic financial maneuvers to enhance shareholder value.